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Modular pathway rewiring of Saccharomyces
cerevisiae enables high-level production of
L-ornithine
Jiufu Qin1,2, Yongjin J. Zhou2, Anastasia Krivoruchko2,3, Mingtao Huang2,3, Lifang Liu2,3, Sakda Khoomrung2,
Verena Siewers2,3, Bo Jiang1 & Jens Nielsen2,3,4
Baker’s yeast Saccharomyces cerevisiae is an attractive cell factory for production of
chemicals and biofuels. Many different products have been produced in this cell factory by
reconstruction of heterologous biosynthetic pathways; however, endogenous metabolism by
itself involves many metabolites of industrial interest, and de-regulation of endogenous
pathways to ensure efﬁcient carbon channelling to such metabolites is therefore of high
interest. Furthermore, many of these may serve as precursors for the biosynthesis of complex
natural products, and hence strains overproducing certain pathway intermediates can serve
as platform cell factories for production of such products. Here we implement a modular
pathway rewiring (MPR) strategy and demonstrate its use for pathway optimization resulting
in high-level production of L-ornithine, an intermediate of L-arginine biosynthesis and a pre-
cursor metabolite for a range of different natural products. The MPR strategy involves
rewiring of the urea cycle, subcellular trafﬁcking engineering and pathway re-localization, and
improving precursor supply either through attenuation of the Crabtree effect or through the
use of controlled fed-batch fermentations, leading to an L-ornithine titre of 1,041±47mg l 1
with a yield of 67mg (g glucose) 1 in shake-ﬂask cultures and a titre of 5.1 g l 1 in fed-batch
cultivations. Our study represents the ﬁrst comprehensive study on overproducing an amino-
acid intermediate in yeast, and our results demonstrate the potential to use yeast more
extensively for low-cost production of many high-value amino-acid-derived chemicals.
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T
he desire to reduce our dependency on petroleum as well
as increasing environmental concerns have stimulated
increased efforts to develop alternative, sustainable pro-
cesses for production of fuels and chemicals from renewable
carbohydrate feedstocks1–3. There is also much interest in using
microorganisms as cell factories for the biosynthesis of natural
products possessing a wide range of biological activities4–7.
Metabolic engineering offers the ability to improve biocatalysts’
properties such as precision and speciﬁcity by redirecting carbon
ﬂuxes in cell factories, and in this context the concept of platform
cell factories is attractive as they can be used as starting point
for efﬁcient production of a range of different chemical
compounds1,8,9. Among the many different chemicals produced
in the framework of metabolic engineering, amino-acid-derived
chemicals have gained much interest7,10–12. Although Escherichia
coli and Corynebacterium glutamicum have been intensively
engineered for production of amino acids13 and amino-acid-
derived chemicals14, baker’s yeast Saccharomyces cerevisiae is an
attractive host for industrial-scale processes because of its
robustness and tolerance towards harsh fermentation conditions
and its approval for production of many food-grade products1.
Furthermore, several unique features of S. cerevisiae, including
GRAS (generally recognized as safe) status, excellent availability
of molecular biology tools15–18 and ability to efﬁciently
express complex enzymes such as cytochrome P450-containing
enzymes5,6,19, make it an even more attractive host for
production of amino-acid-derived products1,7. For instance,
amino-acid metabolism of this yeast has been tailored for
production of higher alcohols that can serve as gasoline
substitutes11,20. In addition, the pathways of aromatic amino
acids including L-tryptophan, L-tyrosine and L-phenylalanine are
widely used for production of various compounds, including
polymer-building blocks21,22 and bioactive natural products such
as benzylisoquinoline alkaloids23. However, the productivity and
yield of these aforementioned amino-acid-derived chemicals are
still very low22, which might be attributed to the complexity of
yeast amino-acid metabolism24. Thus, approaches to rewire the
endogenous amino-acid metabolism are required for increasing
the productivity of amino-acid intermediates and low-cost
production of many high-value amino-acid-derived chemicals
by this cell factory.
L-ornithine, an intermediate of L-arginine biosynthesis, is
widely used as a dietary supplement, as it is known to be
beneﬁcial for the treatment of wound healing and liver disease25.
It can also be used as a precursor for production of putrescine, a
diamine that is used as a nylon monomer14 and natural products
such as tropane alkaloids, which are used as parasympatholytics
for competitively antagonizing acetylcholine26. The biosynthesis
of tropane alkaloids from L-ornithine involves P450 enzymes that
are difﬁcult to express in bacteria, and this limits the potential of
bacterial systems to produce L-ornithine-derived chemicals even
though L-ornithine high-producing bacterial systems have been
achieved27–29. Therefore, there is much interest in developing a
yeast platform cell factory for overproduction of L-ornithine.
Despite extraordinary results of amino-acid production,
including L-ornithine, with C. glutamicum28–30, the complexity
of yeast amino-acid metabolism still calls for different engineering
strategies. Indeed, L-ornithine metabolism is notable for its
complexity in terms of regulation and its connection with
several other pathways, such as biosynthesis of polyamine and
pyrimidine, and the urea cycle. L-arginine biosynthesis is
compartmentalized with the synthesis of L-ornithine in the
mitochondria, but using L-glutamate as substrate, which is
produced in the cytoplasm31. After being transported to the
cytoplasm, L-ornithine is converted to L-arginine in three
consecutive steps. In addition, a-ketoglutarate, the precursor of
L-glutamate, is one of the intermediates of the TCA cycle, the ﬂux
of which is limited in the presence of high glucose concentrations
due to the so-called Crabtree effect32. From this it is obvious
that engineering S. cerevisiae to overproduce L-ornithine is a
daunting task.
According to the above-mentioned characteristics of
L-ornithine metabolism, there are at least four challenges in
constructing an L-ornithine-overproducing yeast strain. First, how
to tune the metabolic ﬂux to produce L-ornithine and not convert
this further into L-arginine without incapacitating cell growth.
Second, how to balance and coordinate the corresponding
pathways and enzymes in different subcellular organelles, as
pathway perturbation could create a limitation in the transport of
intermediates resulting in the redirection of these towards
competing pathways. Third, how to increase the supply of
the precursor a-ketoglutarate, as the Crabtree effect will limit
the TCA cycle efﬁciency for a-ketoglutarate biosynthesis
during normal batch fermentations with excess glucose. Last,
but not least, overall pathway optimization calls for intensive
perturbations of interacting pathways; thus, fast and facile
strategies should be implemented to achieve total pathway
optimization.
To overcome these challenges, here we re-cast the L-ornithine
biosynthesis of yeast into three modules on the basis of the
pathway architecture, using a modular pathway rewiring (MPR)
strategy, and we then completely rewire the L-arginine metabo-
lism to drive increased metabolic ﬂux towards L-ornithine. For
each strategy we evaluate multiple metabolic engineering targets
resulting in evaluation of more than 37 different genetic
modiﬁcations. Through combination of many of the different
metabolic engineering strategies we, in total, construct and
evaluate more than 64 engineered yeast strains, and hereby
gain much new insight into the regulation of L-arginine
biosynthesis in yeast. The best-performing strains have signiﬁcant
rewiring of its arginine metabolism resulting in L-ornithine
production with a titre of 1,041±47mg l 1 in shake-ﬂask
experiments and 5.1 g l 1 in fed-batch fermentations. Our
successful proof-of-concept production of L-ornithine in S.
cerevisiae represents the ﬁrst systematic case study to produce
amino acids in yeast, and it demonstrates the potential to use
yeast as a cell factory platform for the low-cost production of
amino-acid-derived chemicals.
Results
Re-casting L-ornithine biosynthesis into three modules. Overall
optimization of L-ornithine biosynthesis calls for perturbations of
a large number of genes (Fig. 1 and Supplementary Fig. 1), and we
therefore used a MPR strategy that was based on DNA assem-
bly18 and modular pathway engineering (MOPE) methods4 that
enabled efﬁcient optimization of the overall pathway from glucose
to L-ornithine. Hereby, the overall pathway from glucose to
L-ornithine was re-cast into three modules as follows. Module 1:
L-ornithine degradation or consumption module. When L-
ornithine, which is synthesized in the mitochondria, is
transported to the cytoplasm, subsequent reactions can
transform it to L-citrulline or L-glutamate g-semialdehyde by
ornithine carbamoyltransferase (OTC; ARG3) and ornithine
aminotransferase (CAR2), respectively. The arginase reaction
(CAR1) that degrades L-arginine into urea and L-ornithine was
also included in this module (Supplementary Fig. 2); Module 2: L-
ornithine synthesis module. This module contains all the
reactions by which the TCA cycle intermediate a-ketoglutarate
is converted to L-ornithine. Following L-glutamate transport into
the mitochondria from the cytoplasm, ﬁve reaction steps convert
it to L-ornithine. This cyclic L-ornithine synthesis pathway is the
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so-called acetylated derivative cycle because the acetyl group that
is added to L-glutamate in the initial step is recycled from
N-acetyl-L-ornithine generated in the ﬁfth step (Supplementary
Fig. 3); Module 3: a-ketoglutarate synthesis module. This module
includes glucose uptake reactions (including its regulation),
glycolysis and the upstream part of the TCA cycle. The
respiratory chain, which is highly associated with the TCA
cycle ﬂux, is also included in this module (Supplementary Fig. 4).
Our MPR approach was initiated with engineering of the
downstream Module 1 of L-ornithine consumption, and then the
strain with the optimized downstream module was subject to
upstream module optimization. Throughout the manuscript,
strain names indicate the modules present in the strain33, for
example, M1aM2bM3c includes strategy a for Module 1, strategy
b for Module 2 and strategy c for Module 3. See Table 1 and
Supplementary Tables 1 and 2 for descriptions of all strains
constructed in connection with pathway optimization.
Leaky arginine auxotrophy enables L-ornithine production. For
L-arginine biosynthesis, L-ornithine is converted to L-citrulline by
OTC (ARG3)31 in the cytoplasm after L-ornithine is exported
from the mitochondria. The biosynthesis of L-ornithine is hereby
controlled by the presence of L-arginine because of feedback
inhibition and repression of the key enzymes34. Blocking the
consumption pathway of target chemicals completely is a
common strategy for accumulation of desired chemicals, and
this strategy has been successfully applied for L-ornithine
production by C. glutamicum, where the OTC-encoding genes
were fully deleted27,35. However, the entailed L-arginine
auxotrophy of the resulting strains requires L-arginine
supplementation, which might add costs and cause problems
for large-scale operation. We therefore ﬁne-tuned ARG3
expression rather than deleting the gene so that L-arginine can
still be synthesized at low levels to support growth, and this will
also limit any negative regulation of L-arginine on L-ornithine
biosynthesis. We weakened ARG3 expression by replacing its
native promoter with either the glucose-regulated HXT1
promoter (HXT1 encodes a low-afﬁnity glucose transporter of
the major facilitator superfamily) or the low-activity KEX2
promoter (KEX2 encodes a protein-processing Ca2þ -dependent
serine protease)36,37 (Fig. 2a). Both strain M1a (HXT1 promoter)
and M1b (KEX2 promoter) accumulated and secreted L-ornithine
(Fig. 2b, Supplementary Figs 5 and 6). While strain M1a
produced 24mg l 1 L-ornithine, strain M1b had a 76% higher
titre of 42mg l 1 (Fig. 2b). It is interesting that the intracellular
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Figure 1 | Schematic overview of L-ornithine biosynthesis in S. cerevisiae and the main metabolic engineering targets implemented in this study. Genes
or proteins subject to overexpression are shown in red font, while those subject to downregulation or deletion are shown in green and blue, respectively.
Solid arrows represent single reaction steps, while the dashed arrows represent multiple reaction steps. The green arrows represent the related genes or
proteins subject to downregulation, while the red arrows indicate that the related genes or proteins are subject to overexpression. The blue arrows indicate
that the related genes are subject to deletion. CAR1, arginase; CAR2, L-ornithine transaminase; ARG3, ornithine carbamoyltransferase; ARG2, glutamate
N-acetyltransferase; ARG5,6, acetylglutamate kinase and N-acetyl-gamma-glutamyl-phosphate reductase; ARG7, mitochondrial ornithine acetyltransferase;
ARG8, acetylornithine aminotransferase;MLS-argJCg, ornithine acetyltransferase from C. glutamicum located to the mitochondria of S. cerevisiae; MLS-argBCg,
acetylglutamate kinase from C. glutamicum located to the mitochondria of S. cerevisiae; argAEc, glutamate N-acetyltransferase from E. coli; argBEc,
acetylglutamate kinase from E. coli; argCCg, N-acetyl-gamma-glutamyl-phosphate reductase from C. glutamicum; argDCg, acetylornithine aminotransferase
from C. glutamicum; argJCg, ornithine acetyltransferase from C. glutamicum; ORT1, ornithine transporter of the mitochondrial inner membrane; AGC1,
glutamate uniporter; ODC1, transporter of a-ketodicarboxylate or a-ketoglutarate of the mitochondrial inner membrane; GDH1, NADPþ -dependent
glutamate dehydrogenase; GDH3, NADPþ -dependent glutamate dehydrogenase; GLT1, NADþ -dependent glutamate synthase; GLN1, glutamine synthetase;
GDH2, NADþ -dependent glutamate dehydrogenase; CIT1, citrate synthase; PYC2, pyruvate carboxylase isoform; ACO2, putative mitochondrial aconitase
isozyme; IDP1, mitochondrial NADPþ -speciﬁc isocitrate dehydrogenase; PDA1, E1 alpha subunit of the pyruvate dehydrogenase (PDH) complex;
PDA1[S313A], PDA1 with mutation S313A; KGD2, dihydrolipoyl transsuccinylase; MTH1-DT, truncated version of MTH1; Ndi1p, NADH:ubiquinone
oxidoreductase. TCA, tricarboxylic acid cycle; EMP, the glycolysis pathway; HXT, hexose transporter; AOX, NADH alternative oxidase; Q, ubiquinone.
Respiratory chain (complexes III–IV) in the mitochondrial inner membrane is shown as a rectangle, while the ATP synthase (complex V) is shown as a
square. Orn, L-ornithine; Glu, L-glutamate; Gln, L-glutamine; Arg, L-arginine; Cit, L-citrulline; Pro, L-proline; ACTGlu, N-acetyl-L-glutamate; ACTGlu-P,
N-acetylglutamyl-P; ACTGlu-SA, N-acetylglutamate semialdehyde; ACTOrn, N-acetylornithine; AKG, a-ketoglutarate; CIT, citrate; ACO, aconitate;
ICI, isocitrate; OAA, oxaloacetate; AcCoA, acetyl CoA; PYR, pyruvate; SUCC, succinyl-CoA; EtOH, ethanol; ALD, acetaldehyde; Glc, glucose.
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L-arginine level only decreasedB30% compared with the control
(Fig. 2c). It is apparent that the synthesis of L-arginine was to
some extent maintained despite the low-level expression of ARG3.
We speculated that the L-ornithine biosynthetic pathway was
upregulated by the transcription factor Gcn4p (refs 24,38) to
alleviate decreased intracellular L-arginine levels following Arg3p
downregulation, and this may have ensured L-arginine
biosynthesis through the upregulation of genes in the
L-ornithine biosynthetic pathway (Supplementary Fig. 7).
L-ornithine can also be transaminated to L-glutamate
g-semialdehyde by ornithine aminotransferase (Car2p), and
L-glutamate g-semialdehyde can be further converted into
L-glutamate in the presence of oxygen. Deletion of CAR2 may
improve L-ornithine production by blocking this futile cycle.
However, deletion of CAR2 in M1b (strain M1c) resulted in only
a small increase in the L-ornithine titre to 45mg l 1 (Fig. 2b).
This small effect could be attributed to lack of a functional
transaminase reaction at the low L-ornithine level (42mg l 1) in
strain M1b. However, as the Car2p reaction may be activated
when the whole pathway would be further improved for
L-ornithine production, we thus used strain M1c harbouring the
CAR2 deletion as the parent strain for the subsequent pathway
optimization.
Subcellular trafﬁcking engineering and pathway translocation.
After optimization of L-ornithine consumption, we set out to
optimize Module 2 of the L-ornithine biosynthesis pathway from
a-ketoglutarate. This part of L-ornithine biosynthesis is notable
for its compartmentalization, where the key metabolites, such as
L-glutamate, a-ketoglutarate and L-ornithine, are synthesized in
different compartments. Thus, engineering of the speciﬁc
biosynthetic pathway should be coordinated with the transport of
these intermediates. To coordinate transport and biosynthesis
of L-ornithine, we applied three different strategies. First,
improving mitochondrial L-ornithine biosynthesis combined with
engineering of transporters (Fig. 3a). Second, improving mito-
chondrial L-ornithine biosynthesis combined with translocation
of L-glutamate biosynthesis to the mitochondria (Fig. 3b). Last,
but not least, translocation of the entire L-ornithine biosynthetic
pathway to the cytoplasm (Fig. 3c).
The ﬁrst two strategies involved overexpressing genes
of the mitochondrial L-ornithine biosynthetic pathway from
L-glutamate. As expected, overexpression of ARG5,6, ARG7 and
ARG8 in strain M1cM2f resulted in an increased L-ornithine titre
of 59mg l 1, representing a 31% increase compared with the
control strain M1c (Fig. 3d and Supplementary Fig. 8). We also
evaluated overexpression of each of the individual steps of the
Table 1 | Main strains used for module and full pathway optimization
No. Strains Module 1 Module 2 Module 3
Module Description Module Description Module Description
1 M1a M1a PHXT1-ARG3 Null Null Null Null
2 M1b M1b PKEX2-ARG3 Null Null Null Null
3 M1c M1c PKEX2-ARG3; car2D Null Null Null Null
4 M1cM2a M1c PKEX2-ARG3; car2D M2a ARG2 Null Null
5 M1cM2b M1c PKEX2-ARG3; car2D M2b ARG5,6 Null Null
6 M1cM2c M1c PKEX2-ARG3; car2D M2c ARG7 Null Null
7 M1cM2d M1c PKEX2-ARG3; car2D M2d MLS-argBCg Null Null
8 M1cM2e M1c PKEX2-ARG3; car2D M2e MLS-argJCg Null Null
9 M1cM2f M1c PKEX2-ARG3; car2D M2f ARG5,6; ARG7; ARG8 Null Null
10 M1cM2g M1c PKEX2-ARG3; car2D M2g ARG5,6; ARG7; ARG8; ARG2 Null Null
11 M1cM2h M1c PKEX2-ARG3; car2D M2h ARG5,6; ARG7; ARG8; ARG2; ORT1 Null Null
12 M1cM2i M1c PKEX2-ARG3; car2D M2i ARG5,6; ARG7; ARG8; ARG2; ORT1;
MLS-GDH1
Null Null
13 M1cM2j M1c PKEX2-ARG3; car2D M2j ARG5,6; ARG7; ARG8; ARG2; ORT1;
MLS-GDH2
Null Null
14 M1cM2k M1c PKEX2-ARG3; car2D M2k ARG5,6; ARG7; ARG8; ARG2; ORT1; AGC1 Null Null
15 M1cM2l M1c PKEX2-ARG3; car2D M2l ARG5,6; ARG7; ARG8; ARG2; ORT1; AGC1; GDH1 Null Null
16 M1cM2m M1c PKEX2-ARG3; car2D M2m ARG5,6; ARG7; ARG8; ARG2; ORT1; AGC1; GDH3 Null Null
17 M1cM2n M1c PKEX2-ARG3; car2D M2n ARG5,6; ARG7; ARG8; ARG2; ORT1; AGC1; GLN1; GLT1 Null Null
18 M1cM2o M1c PKEX2-ARG3; car2D M2o ARG5,6; ARG7; ARG8; ARG2; ORT1; AGC1; GDH3; ODC1 Null Null
19 M1cM2p M1c PKEX2-ARG3; car2D M2p ARG5,6; ARG7; ARG8; ARG2; ORT1; AGC1; GDH1; ODC1 Null Null
20 M1cM2q M1c PKEX2-ARG3; car2D M2q argAEc;argBEc; argCCg; argDCg; argJCg; ORT1; AGC1; GDH1 Null Null
21 M1cM2r M1c PKEX2-ARG3; car2D M2r PADH1- tGCN4 Null Null
22 M1cM2s M1c PKEX2-ARG3; car2D M2s PTEF1- tGCN4 Null Null
23 M1cM2t M1c PKEX2-ARG3; car2D M2t PGPD1- tGCN4 Null Null
24 M1cM2qM3a M1c PKEX2-ARG3; car2D M2q argAEc;argBEc; argCCg; argDCg; argJCg; ORT1; AGC1; GDH1 M3a PDA1;CIT1;ACO2;
IDP1;PYC2
25 M1cM2qM3b M1c PKEX2-ARG3; car2D M2q argAEc;argBEc; argCCg; argDCg; argJCg; ORT1; AGC1; GDH1 M3b PDA1[S313A];CIT1;
ACO2;IDP1;PYC2
26 M1cM2qM3c M1c PKEX2-ARG3; car2D M2q argAEc;argBEc; argCCg; argDCg; argJCg; ORT1; AGC1; GDH1 M3c HaAOX1
27 M1cM2qM3d M1c PKEX2-ARG3; car2D M2q argAEc;argBEc; argCCg; argDCg; argJCg; ORT1; AGC1; GDH1 M3d HaAOX1; NDI1
28 M1cM2qM3e M1c PKEX2-ARG3; car2D M2q argAEc;argBEc; argCCg; argDCg; argJCg; ORT1; AGC1; GDH1 M3e MTH1-DT
29 M1cM2qM3f M1c PKEX2-ARG3; car2D M2q argAEc;argBEc; argCCg; argDCg; argJCg; ORT1; AGC1; GDH1 M3f MTH1-DT; kgd2D
30 M1dM2q M1d PKEX2-ARG3; car2D M2q argAEc;argBEc; argCCg; argDCg; argJCg; ORT1; AGC1; GDH1 Null Null
31 M1dM2qM3c M1d PKEX2-ARG3; car2D M2q argAEc;argBEc; argCCg; argDCg; argJCg; ORT1; AGC1; GDH1 M3c HaAOX1
32 M1dM2qM3e M1d PKEX2-ARG3; car2D M2q argAEc;argBEc; argCCg; argDCg; argJCg; ORT1; AGC1; GDH1 M3e MTH1-DT
33 M1dM2qM3f M1d PKEX2-ARG3; car2D M2q argAEc;argBEc; argCCg; argDCg; argJCg; ORT1; AGC1; GDH1 M3f MTH1-DT; kgd2D
34 B0166A (ORT1) Null Null Null Null Null Null
Strain names indicate the modules present in the strain, for example, M1aM2bM3c includes strategy a for Module 1, strategy b for Module 2 and strategy c for Module 3.
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pathway to identify if a single enzyme should be ﬂux-controlling,
but single enzyme overexpression did not result in any
improvement in titre over the M1c strain (Supplementary
Fig. 9). This part of the pathway is the so-called acetylated
derivative cycle, where there is cycling of the acetyl group. We
speculated that if the level of acetylated intermediates is increased
there will be a higher catalytic activity of the pathway, and we
therefore also overexpressed N-acetylornithine synthase encoded
by ARG2 resulting in strain M1cM2g producing 80mg l 1 of
L-ornithine, a 36% increase compared with parent strain M1cM2f
(Fig. 3d and Supplementary Fig. 8).
We also evaluated overexpression of the positive regulator
transcription factor Gcn4p (refs 24,38) as an alternative strategy
for overexpression of ARG5,6, ARG7 and ARG8 in the L-ornithine
biosynthetic pathway. We used promoters of different strengths38
to ﬁne-tune expression of a truncated version of GCN4 (tGCN4),
in which the residues 99–106 were truncated to circumvent
rapid degradation of Gcn4p through the ubiquitin pathway38.
However, there was no obvious difference in L-ornithine titre
(Supplementary Fig. 10).
L-ornithine is exported from the mitochondria to the cytosol by
Ort1p (ref. 39) where it is used for L-arginine biosynthesis. In the
ﬁrst strategy we therefore increased the expression level of ORT1
and when this was performed in the M1cM2g strain, resulting in
strain M1cM2h, the L-ornithine titre increased to 115mg l 1,
representing a 44% increase (Fig. 3d and Supplementary Fig. 8).
Encouraged by these ﬁndings we also overexpressed AGC1,
the gene encoding the glutamate uniporter/aspartate–glutamate
exchanger40, to ensure sufﬁcient supply of L-glutamate for
L-ornithine biosynthesis. By overexpression of AGC1 in strain
M1cM2h, resulting in strain M1cM2k, L-ornithine titre increased
to 149mg l 1, representing a further 30% increase (Fig. 3d and
Supplementary Fig. 8). Both strategies point to that internal
trafﬁcking may often be rate-limiting in metabolic pathways, and
overexpressing related transporters may be an efﬁcient strategy
for boosting the pathway ﬂux to chemicals of interest.
Finally, as part of the ﬁrst strategy we engineered L-glutamate
biosynthesis in the cytosol. There are three pathways for
L-glutamate biosynthesis in S. cerevisiae. Two of these are
mediated by the two isoforms of NADPH-dependent glutamate
dehydrogenase, encoded by GDH1 and GDH3, while the third
pathway involves combined activities of glutamine synthetase
(encoded by GLN1) and glutamate synthase (encoded by
GLT1)41. We overexpressed each of the three pathways in
strain M1cM2k, resulting in strains M1cM2l (GDH1), M1cM2m
(GDH3) and M1cM2n (GLN1 and GLT1). Of these targets,
overexpression of GDH1 (strain M1cM2l) resulted in signiﬁcant
improvement in L-ornithine production, that is, a 16% increase in
ﬁnal titre corresponding to 173mg l 1 (Fig. 3d). This indicates
that Gdh1p, which generally is considered the key route for
L-glutamate biosynthesis at ammonia access, is the most efﬁcient
one for L-glutamate biosynthesis, probably because of its
high afﬁnity for a-ketoglutarate42. Subsequently, to boost the
cytoplasmic a-ketoglutarate pool for L-glutamate synthesis, we
also overexpressed Odc1p that is reported to be responsible for
a-ketoglutamate transport from mitochondria to the cytosol in
strains M1cM2l and M1cM2m, respectively; however, this did
not result in any substantial L-ornithine titre improvement
(Supplementary Fig. 11).
In the second strategy, we relocated glutamate biosynthesis into
the mitochondria by re-localizing the most efﬁcient glutamate
dehydrogenase Gdh1p. As Gdh1p is NADPH-dependent and
mitochondria have low levels of NADPH, we also evaluated the
re-localization of Gdh2p, which is NADH-dependent. Contrary
to our expectations, mitochondrial re-localization of Gdh1p
(strain M1cM2i) or Gdh2p (M1cM2j) decreased the L-ornithine
titre signiﬁcantly (Supplementary Fig. 12). The failure of this
strategy may be attributed to either poor functioning of the
glutamate dehydrogenases in the mitochondrial environment or
to metabolite levels disfavouring these reactions in mitochondria.
As the third strategy, we took a different approach and
re-localized the complete L-ornithine biosynthetic pathway to the
cytosol, where the precursor L-glutamate is synthesized.
We introduced a synthetic cytosolic L-ornithine pathway in
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strain M1cM2q, where the genes encoding the ﬁrst two enzymes,
argAEC and argBEc, were from E. coli and the other three pathway
genes, argJCg, argCCg and argDCg, were from C. glutamicum,
a very efﬁcient producer of amino acids, including L-ornithine43.
The successful growth complementation of an L-arginine
auxotrophic S. cerevisiae strain with ORT1 disruption
demonstrated that the cytosolic pathway was functional and
could provide the precursor L-ornithine for L-arginine
biosynthesis (Supplementary Fig. 13). Indeed, the strain
M1cM2q had an 11% increase in L-ornithine production as
compared with strain M1cM2l, resulting in a titre of 192mg l 1
in shake-ﬂask fermentations (Fig. 3d). As indicated in
Supplementary Figs 14 and 15 and Supplementary Table 8, the
speciﬁc L-ornithine titre (mg L-ornithine per g biomass) follows
the same trend as that of the L-ornithine titre among the
recombinant strains as there was no substantial variation in terms
of biomass concentration obtained with the different strains.
These results demonstrated that re-localization of the complete
pathway for L-ornithine biosynthesis into the cytosol was more
successful for L-ornithine production than engineering the
endogenous pathway.
Crabtree effect attenuation improves carbon ﬂux to L-ornithine.
After efﬁciently channelling a-ketoglutarate towards L-ornithine,
we set out to enhance a-ketoglutarate supply by optimizing
Module 3, which involves the conversion of glucose to
a-ketoglutarate. However, the optimization of this part is more
difﬁcult in S. cerevisiae because of the Crabtree effect, that is, the
majority of carbon is channelled towards ethanol via aerobic
fermentation32 when S. cerevisiae is grown aerobically at high
glucose concentrations. The Crabtree effect hereby compromises
carbon ﬂux to the TCA cycle that provides a-ketoglutarate
required for L-ornithine biosynthesis. To overcome this problem,
we evaluated three different strategies. First, overexpression of
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TCA cycle genes involved in the biosynthesis of a-ketoglutarate
(Fig. 4a). Second, improving consumption of NADH generated in
connection with a-ketoglutarate biosynthesis (Fig. 4b). Third,
attenuating glucose uptake rate and hereby reducing overﬂow
metabolism to ethanol (Fig. 4c).
Previous studies showed that a low capacity of the TCA cycle
contributed to the Crabtree effect44, and a comprehensive analysis
of omics data indicated that the TCA cycle ﬂux was to some
extent controlled by phosphorylation of pyruvate dehydrogenase
and one mutation in the pyruvate dehydrogenase complex E1 a
subunit Pda1p was found to bypass this regulation45. As part of
the ﬁrst strategy we therefore overexpressed both wild-type and
mutated PDA1 (PDA1 [S313A]) to drive more ﬂux to L-ornithine
synthesis. In addition, we also overexpressed other genes that
are involved in the conversion of pyruvate to a-ketoglutarate,
including one of the pyruvate carboxylase isomer-encoding gene
PYC2, the citrate synthase-encoding gene CIT1, the aconitase-
encoding gene ACO2 and the isocitrate dehydrogenase-encoding
gene IDP1. The strain M1cM2qM3a, carrying the overexpression
of PDA1, PYC2, CIT1, ACO2 and IDP1, had an L-ornithine titre
of 245mg l 1, representing a 28% increase compared with its
parent strain M1cM2q (Fig. 4d). By contrast, overexpression of
the mutated mPDA1 together with overexpression of PYC2, CIT1,
ACO2, IDP1 (strain M1cM2qM3b) only resulted in a slight
increase in the L-ornithine titre of 264mg l 1 (Fig. 4d) compared
with strain M1cM2qM3a. The strains M1cM2qM3b and
M1cM2qM3a exhibited approximately twofold L-ornithine/
glucose yield as compared with the parent, whereas there was
no substantial difference when compared with the control strain
in terms of ethanol yield, biomass yield and maximum speciﬁc
growth rate (Supplementary Table 8). Thus, with this strategy the
Crabtree effect was not substantially alleviated; however, the
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metabolic ﬂux towards a-ketoglutarate was apparently improved
to some extent.
We previously showed that the Crabtree effect is partly due to a
limited capacity of the respiration chain and that overexpression
of NADH alternative oxidase (AOX) partly alleviated the
overﬂow to ethanol32. We also found that AOX overexpression
resulted in upregulation of almost every step of the TCA cycle,
which may be beneﬁcial for increasing the production of
TCA cycle-derived chemicals, and this was supported by a
previous proteomics study of an AOX-overexpressing strain46.
We therefore overexpressed AOX from Hansenula anomala
(HaAOX1) and also NDI1 encoding the endogenous NADH
dehydrogenase, which mediates the delivery of electrons
to the respiratory chain. Overexpression of HaAOX1 (strain
M1cM2qM3c) resulted in an L-ornithine titre of 258mg l 1,
representing a 35% increase as compared with the parent strain
M1cM2q (Fig. 4d). Combined overexpression of NDI1 and
HaAOX1 further increased L-ornithine production to 278mg l 1
(Fig. 4d). These results indicated that overexpression of
alternative NADH oxidase was an efﬁcient strategy to boost the
TCA cycle ﬂux for the production of TCA cycle-derived amino
acids. Interestingly, overexpression of HaAOX1 and NDI1 (strain
M1cM2qM3d) increased L-ornithine production to the same
level as boosting the TCA cycle’s enzyme activity by direct
overexpression of the related genes (strain M1cM2qM3b; Fig. 4d).
Although the two strategies described above had a positive
effect on L-ornithine production, the Crabtree effect still caused
low yields of L-ornithine on glucose, with ethanol being a major
by-product. Previous work indicated a strong positive correlation
between the Crabtree effect and glucose uptake rate during
respirofermentative growth of S. cerevisiae44, and a recent study
found that an internal deletion in the hexose transporter
regulation protein Mth1p, encoded by MTH1-DT, interfered
with its degradation and caused a decrease in expression of these
transporter proteins and hence a reduced glucose uptake rate47.
As the third strategy, we therefore overexpressed MTH1-DT
(strain M1cM2qM3e) resulting in a remarkable fourfold increase
in L-ornithine titre up to 778mg l 1 (Fig. 4d). With MTH1-DT
expression there was also no ethanol produced; however,
the glucose uptake rate was reduced to 0.2 g glucose
(g DCW) 1 h 1, compared with the parent strain that had an
ethanol production of 1.3 g ethanol (g DCW) 1 h 1 and a
glucose uptake rate of 2.2 g glucose (g DCW) 1h 1 (Fig. 4e).
These results demonstrated that alleviating the Crabtree effect of
S. cerevisiae was an efﬁcient strategy to boost L-ornithine
production at high glucose concentrations.
Low activity of a-ketoglutarate dehydrogenase (ODC), which
catalyses the oxidative decarboxylation of a-ketoglutarate to
succinyl-CoA in the TCA cycle, was found to be essential for
glutamate overproduction in C. glutamicum48, and, inspired by
this, we reasoned that ODC attenuation might redirect more TCA
ﬂux to the biosynthesis of L-ornithine. However, deletion of
KGD2 encoding one of the components of the mitochondrial
a-ketoglutarate dehydrogenase complex decreased the L-ornithine
titre byB90% (Supplementary Fig. 16). Interestingly, the glucose
uptake and the ethanol production rate of KGD2 deletion strain
(Strain M1dM2qM3f) increased to 2.2 g glucose (g DCW) 1h 1
and 0.9 g ethanol (g DCW) 1h 1, respectively (Supplementary
Table 7).
Clearly alleviation of the Crabtree effect has a positive effect on
the L-ornithine titre and yield. Even though overexpression of
MTH1-DT was found to be an efﬁcient strategy for alleviating the
Crabtree effect in shake-ﬂask cultures, it would be less attractive
for industrial production as the strain has reduced growth. We
therefore explored the possibility of alleviating the Crabtree effect
by using an aerobic glucose-limited fed-batch strategy with strain
M1cM2qM3a, whose upstream TCA cycle was enhanced as
described above. This resulted in a ﬁnal L-ornithine titre of
5.1 g l 1 and a ﬁnal DCW of 56 g l 1 (Supplementary Fig. 17).
Urea cycle engineering enables L-ornithine titre improvement.
S. cerevisiae has the potential to operate the urea cycle: arginase
(encoded by CAR1) can degrade L-arginine into urea and
L-ornithine. To further increase L-ornithine synthesis and reduce
the L-arginine pool, which can cause feedback inhibition, we also
overexpressed CAR1. As expected, overexpression of CAR1 in the
strain M1cM2qM3e (resulting in strain M1dM2qM3e) enabled a
ﬁnal L-ornithine titre of 1,041mg l 1, representing a further
34% increase. This ﬁnal strain has a 23-fold improvement in
L-ornithine production compared with strain M1c (Fig. 4d). An
early study showed that in the presence of L-arginine and
L-ornithine, OTC (Arg3p) and arginase (Car1p), both trimeric
proteins, can form the so-called ‘epi-arginase’ mode of regulation,
that is, a one-to-one complex in which arginase remains active
but OTC activity is inhibited31. This regulation prevents the
formation of an L-ornithine futile cycle when the biosynthesis of
L-arginine is repressed and the catabolism of L-arginine is
activated31. We speculate that overexpression of CAR1 also
possibly improved the ‘epi-arginase’ efﬁciency and the ﬂux from
L-ornithine to L-arginine was well controlled at a moderate level.
Discussion
Metabolic engineering in yeast is often hampered by extensive
regulation of its metabolism, which evolved to ensure robustness.
Extensive genetic perturbations therefore have to be implemented
in a coordinated manner to achieve high-level production
of desired chemicals, especially pathway intermediates. We
demonstrated that a MPR strategy enabled a coordinated increase
in ﬂux towards L-ornithine. The MPR approach involved
implementation of a large number of perturbations in the
metabolism, ranging from the central carbon metabolism to the
dedicated amino-acid biosynthetic pathway. Here we used a serial
approach; however, recent advances in molecular biology tools for
yeast and other eukaryotic organisms15,17,49,50 will enable
concurrent tinkering of the many different pathway modules
considered here.
Enhancement of the precursor supply is a very common
strategy in bacteria to increase the ﬂux towards the desired amino
acids13,43,51. Yet, the segmentation of precursor intermediates in
different subcellular organelles in S. cerevisiae hampers the plug
and play use of such approaches52,53. Thus, we tested a serial of
customized approaches for yeast to improve precursor supply for
L-ornithine synthesis. When we implemented Module 2, a
substantial increase in L-ornithine titre was observed when the
mitochondrial trafﬁcking steps of L-ornithine and L-glutamate
were enhanced by overexpressing the related proteins belonging
to the mitochondrial carrier family, suggesting the mitochondrial
subcellular trafﬁcking often to be ﬂux-controlling steps. However,
when we implemented the overexpression of ODC1, which was
suggested to encode one of the transporters responsible for
the export of a-oxoglutarate and a-oxoadipate from the
mitochondrial matrix to the cytosol, where they are required
for glutamate and lysine biosyntheses, the L-ornithine titre did not
substantially increase. This could be due to a low level of
a-ketoglutamate in the mitochondria; however, it may also be
such that Odc1p is not a speciﬁc transporter responsible for the
efﬂux of a-ketoglutamate from the mitochondrial matrix to the
cytosol. Thus, while the identiﬁcation of new mitochondrial
carriers including the said a-ketoglutamate mitochondrial
transporter in yeast will provide new insights into the
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physiological roles of mitochondrial carriers in cell metabolism, it
would also allow for improved metabolic engineering.
In other studies, pathway re-localization was shown to be a
successful strategy to improve the production efﬁciency of desired
chemicals11,20,54. Owing to the concentration of enzymes and
intermediates, reduction in toxic effects of certain intermediates
and prevention in the diversion of precursor ﬂux into competing
pathways11,53,54, re-localization of the metabolic pathways to the
mitochondria was shown to be a useful strategy in metabolic
engineering11,53,54. However, in contrast to the substantial
increase in L-ornithine titre when we introduced the bacterial
acetylated derivatives cycle into the cytoplasm, targeting
NADPH-dependent glutamate dehydrogenase (Gdh1p) to the
mitochondria markedly decreased the L-ornithine titre. These
results highlight the importance of carefully choosing the re-
localization strategy for metabolic engineering, and our results
demonstrate that it may be better to express a heterologous
bacterial pathway in the cytosol than to de-regulate the
endogenous mitochondrial pathway. Similarly, one recent work
showed that cytosolic pathway re-localization increased
isobutanol production substantially in S. cerevisiae and also
showed that further blocking of the parallel mitochondrial
L-valine pathway, which generated the driving force for the
cytosolic isobutanol pathway, resulted in even higher isobutanol
production20.
Although iterative engineering improved L-ornithine produc-
tion to 192mg l 1 in strain M1cM2q, the L-ornithine yield on
glucose was only 9.6mg (g glucose) 1; moreover, several studies
reported similarly low yields on the carbon substrate21–23 after
metabolic engineering of S. cerevisiae for production of chemicals,
especially amino-acid-derived molecules. One of the main
reasons is the Crabtree effect by which substantial carbon ﬂux
is redirected to ethanol production44,55,56. Through optimization
of Module 3, we showed that several different strategies worked
and overexpression of a truncated form of MTH1, that is,
MTH1-DT, was the most successful one for increasing the
L-ornithine yield as it generally alleviates the Crabtree effect even
when the cells are grown at high glucose concentrations.
However, the reduced maximum speciﬁc growth rate compared
with that of the parent strain makes this strategy less attractive for
large-scale process, where the Crabtree effect can be avoided
through the use of fed-batch fermentations as also demonstrated
here. Still, overexpression of MTH1-DT for reducing the
substrate uptake and the associated overﬂow metabolism is here
demonstrated to be a useful strategy for evaluation of engineering
strategies in shake-ﬂask cultures.
In conclusion, despite the complexity of the L-ornithine
biosynthetic pathway, our results demonstrate great promise for
engineering of yeast for production of amino acids using the MPR
approach. The L-ornithine biosynthesis and regulation, pathway
compartmentalization and overﬂow metabolism were system-
atically modiﬁed for L-ornithine overproduction. This ﬁrst
successful proof-of-concept of L-ornithine production in S.
cerevisiae showed the potential to engineer other fungal microbial
cell factories for production of amino acids and amino-acid-
derived chemicals. In addition, our engineered strains and
strategies described here should facilitate future engineering of
complex biosynthetic pathways for production of different
natural products derived from L-ornithine and even other amino
acids intermediates.
Methods
Yeast strains and plasmids. All engineered strains (Supplementary Table 1 and
Supplementary Table 2) were constructed from S. cerevisiae strain CEN.PK 113-
11C (MATa SUC2 MAL2-8c his3D1 ura3-52). Genetic engineering based on plas-
mids or chromosomal integration was performed following ‘DNA assembler’18 and
‘MOPE strategy’4. Detailed pathway construction procedures including promoter
replacement, chromosome integration and plasmid construction are described in
the Supplementary Methods and Supplementary Tables 3, 5 and 6. All PCR
primers used are listed in Supplementary Table 4.
Media. Yeast strains without plasmids were maintained on YPD plates (10 g l 1
yeast extract, 20 g l 1 casein peptone, 20 g l 1 glucose and 20 g l 1 agar). Plasmid
carrying yeast strains were selected on synthetic dextrose (SD) plates (6.7 g l 1
yeast nitrogen base (amino acids free), 20 g l 1 glucose and 20 g l 1 agar) with
uracil and histidine omitted when appropriate. Deﬁned minimal medium (Delft
medium)37 was used for both batch cultivations and fed-batch fermentations of
L-ornithine-producing strains. Detailed procedures of both shake-ﬂask batch
fermentation and fermenter fed-batch fermentation can be found in the
Supplementary Methods.
Cell dry weight measurement. The cell dry weight was measured by ﬁltering
known volumes of the cultures through pre-dried and pre-weighed 0.45-mm-pore
size nitrocellulose ﬁlters. The ﬁlters with the biomass were washed with water,
dried for 15min in a microwave oven at 150W and weighed again. The optical
density at 600 nm was determined using a Hitachi U-1100 spectrophotometer. For
the intracellular concentration estimation, the cell volume (VC) was calculated to
VC¼ 2.38ml (g CDW) 1 (ref. 57).
Extracellular metabolite detection using HPLC. Concentrations of glucose and
ethanol were analysed by an isocratic high-performance liquid chromatograph
(UltiMate 3000 Nano, Dionex) with an Aminex HPX-87H ion-exchange column
(Bio-Rad, Hercules, CA) at 45 C, and 5mM H2SO4 as the mobile phase at a ﬂow
rate of 0.6mlmin 1. Glucose and ethanol were measured with a refraction index
detector (RI-101 Refractive Index Detector, Shodex).
L-arginine and L-ornithine extraction and quantiﬁcation. Leakage-free
quenching was performed before exaction according to ref. 58. Intracellular
L-arginine and L-ornithine were extracted by using the Hot Water Extraction
protocol, which was modiﬁed and performed according to ref. 58 with minor
modiﬁcations. Then, both extracellular and intracellular L-arginine detections were
performed with an L-arginine rapid detection Kit (Megazyme K-LARGE, Wicklow,
Ireland), and L-ornithine was measured using a ninhydrin colorimetric assay as
described previously59.
L-ornithine qualitative analysis with GC–MS. The analysis of extracellular L-
ornithine samples was performed according to ref. 60. Brieﬂy, L-ornithine was
derivatized by tert-butyldimethylsilylation and further analysed with GC–MS.
Conﬁrmation of the identity of L-ornithine from the sample was achieved by
comparing its retention time and mass spectrum with the synthetic standard under
identical measurement conditions.
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